Exogenesis

United States
Billerica, Massachusetts, United States, 01821

Company profile

Exogenesis company profile

Exogenesis Corporation engages in developing and processing implantable vascular stents, orthopedic devices, and other medical products utilizing its gas cluster ion beam technology. It offers ClusterCoat Processing System, a room temperature method for modifying the physical and chemical properties of outermost atomic layers of surface while leaving the underlying bulk of the unaffected material. The company was founded in 2005 and is based in Billerica, Massachusetts.

Business identity

Contact email
[email protected]
Phone number
978-439-0120
Operating status
Active
Company type
For Profit
Employee range
11-50 employees
Revenue range
$0-$1M
Founded
2005-01-01, Year

Headquarters

Postal code
01821
Country code
US
Continent
North America

Capital profile

Funding and company signals

Funding rounds
2
Total equity funding
$7.8M
Last funding
Series Unknown / $3.2M / 2010-12-01
Last equity funding
Series Unknown / $3.2M
Investors
3
Founders
1
Articles
10

Founders and investors

Founders

Richard Svrluga

Investors

Inflection Point VenturesJDSU (now Viavi Solutions)Venture Capital Fund of New England